Modelling of the relationship between ustekinumab exposure, faecal calprotectin and endoscopic outcomes in patients with Crohn's disease

被引：0
|
作者：
Wang, Z. [1 ]
Verstockt, B. [2 ,3 ]
Vermeire, S. [2 ,3 ]
Sabino, J. [2 ,3 ]
Ferrante, M. [2 ,3 ]
Declerck, P. [1 ]
Dreesen, E. [1 ,4 ]
机构：
[1] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[4] Uppsala Univ, Dept Pharm, Uppsala, Sweden
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.431
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P307
引用
收藏
页码：S335 / S336
页数：4
相关论文
共 50 条
  • [41] Relationship of faecal calprotectin and long-term outcomes in Finnish adult patients with Crohn's disease: Retrospective multi-centre chart review study
    Hallinen, T.
    Jussila, A.
    af Bjorkesten, C. -G.
    Kemppainen, H.
    Soini, E.
    Mankinen, P.
    Valgardsson, S.
    Veckman, V.
    Nissinen, R.
    Molander, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S213 - S213
  • [42] Relationship between Ustekinumab Trough Concentrations and Clinical, Biochemical and Endoscopic Outcomes in Crohn's Disease; A Multi-Center Nationwide Study (TARGET STUDY)
    Shehab, M.
    Alrashed, F.
    Abdullah, I.
    Alfadhli, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1473 - I1473
  • [43] Relationship between ustekinumab trough concentrations and both clinical and biological remission in patients with Crohn's disease
    Dominguez, Francisco Angel Lao
    Lozano, Maria Jose Fobelo
    Pizarraya, Antonio Gutierrez
    Fernandez, Manuel Castro
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (08): : 631 - 632
  • [44] Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn's Disease
    Straatmijer, T.
    Biemans, V. B. C.
    Moes, D. J. A. R.
    Hoentjen, F.
    ter Heine, R.
    Maljaars, P. W. J.
    Theeuwen, R.
    Pierik, M.
    Duijvestein, M.
    van der Meulen, A. E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I340 - I341
  • [45] Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease
    Hisashi Hirayama
    Yasuhiro Morita
    Takayuki Imai
    Kenichiro Takahashi
    Atsushi Yoshida
    Shigeki Bamba
    Osamu Inatomi
    Akira Andoh
    BMC Gastroenterology, 22
  • [46] Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease
    Hirayama, Hisashi
    Morita, Yasuhiro
    Imai, Takayuki
    Takahashi, Kenichiro
    Yoshida, Atsushi
    Bamba, Shigeki
    Inatomi, Osamu
    Andoh, Akira
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [47] Diagnostic accuracy of faecal calprotectin in Crohn's disease - Does disease location matter?
    Simon, E.
    Wardle, R.
    Thi, A. A.
    Eldridge, J.
    Samuel, S.
    Moran, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S141 - S142
  • [48] Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease
    Tessa Straatmijer
    Vince B. C. Biemans
    Dirk Jan A. R. Moes
    Frank Hoentjen
    Rob ter Heine
    P. W. Jeroen Maljaars
    Rosaline Theeuwen
    Marieke Pierik
    Marjolijn Duijvestein
    Andrea E. van der Meulen-de Jong
    Digestive Diseases and Sciences, 2023, 68 : 2647 - 2657
  • [49] Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease
    Straatmijer, Tessa
    Biemans, Vince B. C.
    Moes, Dirk Jan A. R.
    Hoentjen, Frank
    ter Heine, Rob
    Maljaars, P. W. Jeroen
    Theeuwen, Rosaline
    Pierik, Marieke
    Duijvestein, Marjolijn
    van der Meulen-de Jong, Andrea E. E.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2647 - 2657
  • [50] The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis
    Bohra, Anuj
    Mohamed, Ghada
    Vasudevan, Abhinav
    Lewis, Diana
    Van Langenberg, Daniel R. R.
    Segal, Jonathan P. P.
    BIOMEDICINES, 2023, 11 (05)
12345